Umeclidinium bromide is a long-acting muscarinic acetylcholine antagonist used in combination with vilanterol, a b2 agonist, for the treatment of chronic obstructive pulmonary disease.
Due to umeclidinium’s poor oral bioavailability, the drug is administrated by inhalation as dry powder.